Founded by @FlagshipPioneer, Cellarity is developing medicines through an understanding of cell behaviors.
Cambridge, Massachusetts
Joined February 2019
- Tweets202
- Following468
- Followers1.7K
- Likes150
Cellarity is pleased to welcome Ted Myles as Chief Executive Officer. For more: cellarity.com/news_item/ted-…
ALT Cellarity is pleased to announce Ted Myles has joined the company as Chief Executive Officer
Cellarity is pleased to welcome Alec Reynolds as interim President, bringing 17+ years of drug development, strategy & partnering expertise from Celgene & Flagship Pioneering Medicines, where he is COO. Thank you, Fabrice Chouraqui, for your leadership. 🔗cellarity.com/about/?filter=…
Our Chief Medical Officer Cameron Trenor spoke with @PharmaVoice to discuss challenges facing #SickleCell disease treatments and how Cellarity is approaching a new option for patients.
🔗More at bit.ly/3YZS3PY
#SCD #BiggerLeaps
In October, we welcomed industry peers for #medSCAI24 to share insights, collaborate & explore the future of #AI & #MachineLearning to foster advancements across industry & academia. We look forward to continuing the conversations sparked at this year’s event. #BiggerLeaps
⏰ Only 8 days until #medSCAI24! Register for this symposium on the cutting edge of medicines, single cell and #AI and #MachineLearning.
Secure your spot ➡️ bit.ly/3yOdJEL
#BiggerLeaps
Thrilled to announce our #medSCAI24 panel on realizing AI's full translational impact on drug development.
Register ➡️ bit.ly/3yOdJEL
@RLCscienceboss, @1910Genetics, @nvidia, @novonordisk, @Novartis
What do you want to discuss with or hear from leaders at the cutting edge of medicines, single cell and AI/machine learning at medSCAI 2024?
0%Data Quality & Collabs
100%AI in Clinical Trials
0%AI Regs & Guidelines
0%Other? Comment!
1 votes • Final resultsAttend #medSCAI24—our 3rd annual symposium on medicines, single cell tech & #AI! Join leaders for two sessions on AI & #MachineLearning-powered #DrugDiscovery. Featuring @ArpeggioBio, @MITdeptofBE, @uwgenome, @Novartis & more.
Register ➡️ bit.ly/3yOdJEL
Our Chief Data Officer Parul Bordia Doshi joins the 🎙Data in Biotech podcast to explore how #AI & single-cell multiomics are transforming #DrugDiscovery.
Listen to the episode:
pod.co/data-in-biotech/trans…
Introducing #medSCAI24! We’re bringing together the top minds in #AI and #MachineLearning to tackle barriers to using new technology to bring medicines to patients faster. Don’t miss keynote speaker Aviv Regev of @genentech. Join us: cellarity.com/symposium/ #BiggerLeaps
Our CEO Fabrice Chouraqui tells @PharmExec how our cutting-edge platform is transforming the treatment of MASH in partnership with @novonordisk. The future of medicine is here, and our platform is leading the way.
Learn more: bit.ly/3WeCjpM
Cellarity CEO Fabrice Chouraqui joins @Biotech2050Pod's @rahulc to discuss his career journey, and the shared language and mindset of our teams working to harness #AI and #MachineLearning to bring innovative medicines to patients.
🎙️ Listen: open.spotify.com/episode/71u…
Our CEO Fabrice Chouraqui & @medicine_maker discuss how Cellarity’s platform uses #AI and #ML to re-envision #DrugDiscovery & the impact approaches like ours could have on people living with disease and in need of new therapies.
Read the Q&A: bit.ly/4cF3AYQ
We’re focusing on the whole cell to transform drug discovery. Hear from our CEO Fabrice Chouraqui on @PharmExec about our drug candidate with gene-therapy-like efficacy in a once-daily pill to treat sickle cell disease:
bit.ly/4cO02UL
Our CEO Fabrice Chouraqui explains the power of our drug discovery platform in a new interview with @PharmExec. Listen here: bit.ly/3WegtTc
We're thrilled to announce that we've appointed Percy Carter, MBA, Ph.D., to our Board of Directors! Dr. Carter's leadership will help accelerate our work to bring value to patients via novel biology and differentiated drug candidates.
Welcome, Percy! bwnews.pr/3YpvOD8
Companies pioneering original science are essential to bring about new medicines. We are proud to be one with our Al/ML solution to repeatedly generate disease-modifying medicines against dysfunctional cellular biology as part of the #FlagshipFounded ecosystem.
Flagship Pioneering raises $3.6 billion to fuel critical breakthroughs in human health and sustainability. This expanded capital pool will accelerate the impact of original science and the creation and development of an estimated 25 breakthrough companies in human health, sustainability, and artificial intelligence. Hear from Flagship Founder and CEO @NoubarAfeyan about how we're taking #BiggerLeaps by leveraging the power of generative AI, forging novel partnerships with pharma to speed drug development, expanding globally, and promoting and hiring top talent to our leadership ranks. Read the full press release: bit.ly/4eQfx05
Our CEO Fabrice Chouraqui spoke with @DrugTargetRev to explain how Cellarity is using #AI and #MachineLearning to predict and prevent drug toxicity, potentially reducing treatment costs. More: bit.ly/4cfeODT
Our CEO Fabrice Chouraqui is featured in @statnews discussing how we're revolutionizing drug discovery by looking at the whole cell instead of a singular target using AI/ML. Learn more about our innovative work and vision for the future of health care! bit.ly/3XGsB1Z
#SickleCellDisease impacts 5M+ globally, leading to excruciating pain crises & other complications. At Cellarity, we're working hard to provide hope to these patients & are celebrating #WorldSickleCellDay. Learn more: bit.ly/4evHPgc
#HopeThroughProgress #ThroughThePain